OKYO Pharma Limited, (OKYO): Price and Financial Metrics
OKYO Price/Volume Stats
| Current price | $1.86 | 52-week high | $1.98 |
| Prev. close | $1.88 | 52-week low | $0.81 |
| Day low | $1.84 | Volume | 23,400 |
| Day high | $1.97 | Avg. volume | 160,323 |
| 50-day MA | $1.45 | Dividend yield | N/A |
| 200-day MA | $1.20 | Market Cap | 62.93M |
OKYO Stock Price Chart Interactive Chart >
OKYO Pharma Limited, (OKYO) Company Bio
OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. It is developing OK-101 for the treatment of dry eye disease; and OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. The company is also developing chemerin and chemerin analogues to treat the cytokine release syndrome associated with COVID-19 infections and other conditions, such as acute respiratory distress syndrome. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.
OKYO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
OKYO Price Returns
| 1-mo | 26.60% |
| 3-mo | 30.07% |
| 6-mo | 78.85% |
| 1-year | 38.81% |
| 3-year | -5.10% |
| 5-year | N/A |
| YTD | 61.75% |
| 2024 | -35.03% |
| 2023 | -7.33% |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |